Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. CART

Go back to Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)

Endocyte (ECYT) Removed from Wedbush's Best Ideas List

May 5, 2014 10:21 AM EDT

Wedbush maintained an Outperform rating on Endocyte (NASDAQ: ECYT) but removed the stock from its Best Ideas List. Its price target was reduced to $26.00 (from $65.00).

Analyst Gregory R. Wade said, "The Data Safety... More

Baird Downgrades Endocyte (ECYT) to Neutral

May 2, 2014 10:17 AM EDT

Baird downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral with a price target of $8.00.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $17.38 yesterday.

... More

Piper Jaffray Downgrades Endocyte (ECYT) to Neutral

May 2, 2014 9:03 AM EDT

Piper Jaffray downgraded Endocyte (NASDAQ: ECYT) from Overweight to Neutral with a price target of $13.50.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $17.38 yesterday.

... More

Endocyte, Inc. (ECYT) trading halted with news pending

May 2, 2014 7:57 AM EDT

Endocyte, Inc. (NASDAQ: ECYT) trading halted with news pending.

... More